FDA Neutral on Moderna Bid for Booster Ahead of Decisive Meeting FDA Neutral on Moderna Bid for Booster Ahead of Decisive Meeting

Moderna is requesting that the FDA authorize a booster for its COVID vaccine regimen at half its original dose.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news